Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits

Nature Medicine

Volumn 5, Issue 1, 1999, Pages 107-111

  Levi, Marcel ^a   Friederich, Philip W ^a   Middleton, Sarah ^b   De Groot, Philip G ^c   Wu, Ya Ping ^c   Harris, Roy ^b   Biemond, Bart J ^a   Heijnen, Harry F G ^c   Levin, Jack ^d   Ten Cate, Jan Wouter ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Andaris Ltd   (United Kingdom)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BUSULFAN; FIBRINOGEN; SYNTHOCYTE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING TENDENCY; BLOOD SUBSTITUTION; DRUG FORMULATION; HEMOSTASIS; MICROCAPSULE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ALBUMINS; ANIMALS; BLOOD PLATELETS; BLOOD SUBSTITUTES; CAPSULES; DISEASE MODELS, ANIMAL; FIBRINOGEN; HEMORRHAGE; HUMANS; RABBITS; THROMBOCYTOPENIA; THROMBOSIS; TIME FACTORS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 17444405937     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/4795     Document Type: Article

References (18)

1. Roy, A.J., Jaffe, N. & Djerassi, I. Prophylactic platelet transfusions in children with acute leukemia. A dose response study. Transfusion 13, 283-290 (1973).
2. Rebulla, P. et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N. Engl. J. Med. 337, 1870-1875 (1997).
3. National Institute of Health Consensus Conference. Platelet transfusion therapy. Tronsfus. Med. Rev. 1, 195-200 (1987).
4. nd edn. (eds. Hoffman, R. et al.) 419-421 (Churchill Livingstone, New York, 1995).
5. The Trial to Reduce Alloimmunization to Platelets Study Group. Leucocyte reduc-tion and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N. Engl. J. Med. 337, 1861-1869 (1997).
6. Dodd, R.Y. The risk of transfusion-transmitted infection. N. Engl. J. Med. 327, 419-421 (1992).
7. Yen, R.C.K., Ho, T.W.C. & Blajchman M.A. A novel approach to correcting the bleeding time in thrombocytopenic rabbits. Transfusion 35, 415 (1995).
8. Rodgers, R.P. & Levin, J. A critical reappraisal of the bleeding time. Semin. Thromb. Hemost. 16, 1-20 (1990).
9. Evatt, B.L., Levin, J. & Algazy, K.M. Partial purification of thrombopoietin from the plasma of thrombocytopenic rabbits. Blood 54, 377-388 (1979).
10. Blajchman, M.A. & Lee, D.H. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes. Transf. Med. Rev. 11, 99-105 (1997).
11. Kuter, D.J. & Rosenberg, R.D. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 85, 2710-2730 (1995).
12. Blajchman, M.A. et al. Shortening of the bleeding time in rabbits by hydrocortisone caused inhibition of prostacyclin generation by the vessel wall. J. Clin. Invest. 63, 1026-1035 (1979).
13. Benedict, C.R. et al. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA. Circulation 92, 3032-3040 (1995).
14. Levi, M., Biemond, B.J., van Zonneveld, A.J., ten Cate, J.W. & Pannekoek, H.: Inhibition of plasminogen activator inhibitor 1 (PAI-1) activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis. Circulation 85, 305-312 (1992).
15. Sakariassen, K.S., Aarts, P.A., de Groot, P.G., Houdijk, W.P. & Sixma, J.J. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J. Lab. Clin. Med. 102, 522-535 (1983).
16. Zwaginga, J.J. et al. Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts. Arteriosclerosis 10, 437-448 (1990).
17. van Breugel, H.F., de Groot, P.G., Heethaar, R.M. & Sixma, J.J. Role of plasma viscosity in platelet adhesion. Blood 80, 953-959 (1992).
18. Saelman, E.U.M. et al. Aggregate formation is more strongly inhibited at high shear rates by dRCDW, a synthetic RGD-containing peptide. Arterioscler. Thromb. 13, 1164-1170 (1993).